Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLFN11 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-17 |
mRNA | TMPO | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |
mRNA | SAFB | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-12 |
mRNA | ELAVL1 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
mRNA | PROSER1 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
mRNA | ILF3 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
mRNA | YIPF5 | CTRPv2 | pan-cancer | AAC | -0.25 | 7e-11 |
mRNA | SFPQ | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-10 |
mRNA | HNRNPA1 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-10 |
mRNA | HDAC2 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-10 |